Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly TP-HDFL in Advanced Transitional Cell Carcinoma
NCT00154687Phase 2Completed
- Sponsor
- National Taiwan University Hospital
- Start
- Oct 2000
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of paclitaxel, cisplatin, fluorouracil and folinic acid in transitional cell carcinoma (TCC), sponsored by National Taiwan University Hospital. Primary endpoint: Objective Response Rate. Started Oct 2000; status: completed.
02
Drugs
paclitaxelcisplatinfluorouracilfolinic acid
03
Conditions
transitional cell carcinoma (TCC)
Beyond the preview
Go deeper on NCT00154687.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00154687.